Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

DEMONSTRATION OF PRECISE RELATIONSHIPS AND LINKS BETWEEN TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND PARKINSON’S DISEASE

View through CrossRef
Diabetes is a metabolic disorder that intessssrferes with the body's ability to consume food and convert it into energy. The most common mode of diabetes in type 2 diabetes mellitus (T2DM) is that the body cannot effectively use insulin produced by the pancreas. This is called insulin resistance. Parkinson's Disease (PD) is a chronic neurodegenerative motor defect whose properties work is hindrance with locomotion. This is due to the loss of neurons in the substantia nigra area under the brain that produces dopamine, a chemical messenger that transmits signals that produce smooth, meaningful movement. Dopamine loss caused by neuronal damage and death causes impaired movement. Cells rely on glucose for energy, and insulin helps to convert glucose into energy. In both Parkinson's disease and type 2 diabetes, changes in the brain can result in signaling interruptions that affect normal functioning. Insulin resistance also reaches the brain and produces severe changes in the nerve cells, increasing the risk of Parkinson's disease and abnormally promoting high blood sugar leads to high-rise the inflammation, associated with the development of Parkinson's disease. Diabetes suffering peoples are more likely to have Parkinson's disease. Parkinson's disease is 32% higher in people with type 2 diabetes than in non-diabetic patients. Patients with type 2 diabetes along with its complication have a 49% higher risk of Parkinson’s disease, while those having only type 2 diabetes without complications have a 30% risk of parkinson’s disease. In particular, younger patients with diabetes (25 to 44 years of age) have an approximately fourfold increased risk of developing Parkinson's compared with adults of similar age without diabetes. Researchers has estimated the high risk of developing PD based on longitudinal data methodology for people with type 2 diabetes. Initial studies have reported more than 400 genes linked in both conditions. The potential link between type 2 diabetes and Parkinson's disease has been the topic of medical dialogue and scientific research for years. Recently, animal and in vitro studies have shown that the pathophysiology and clinical symptoms of Parkinson's disease are concerned more with insulin dysregulation and changes in insulin action.
Title: DEMONSTRATION OF PRECISE RELATIONSHIPS AND LINKS BETWEEN TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE AND PARKINSON’S DISEASE
Description:
Diabetes is a metabolic disorder that intessssrferes with the body's ability to consume food and convert it into energy.
The most common mode of diabetes in type 2 diabetes mellitus (T2DM) is that the body cannot effectively use insulin produced by the pancreas.
This is called insulin resistance.
Parkinson's Disease (PD) is a chronic neurodegenerative motor defect whose properties work is hindrance with locomotion.
This is due to the loss of neurons in the substantia nigra area under the brain that produces dopamine, a chemical messenger that transmits signals that produce smooth, meaningful movement.
Dopamine loss caused by neuronal damage and death causes impaired movement.
Cells rely on glucose for energy, and insulin helps to convert glucose into energy.
In both Parkinson's disease and type 2 diabetes, changes in the brain can result in signaling interruptions that affect normal functioning.
Insulin resistance also reaches the brain and produces severe changes in the nerve cells, increasing the risk of Parkinson's disease and abnormally promoting high blood sugar leads to high-rise the inflammation, associated with the development of Parkinson's disease.
Diabetes suffering peoples are more likely to have Parkinson's disease.
Parkinson's disease is 32% higher in people with type 2 diabetes than in non-diabetic patients.
Patients with type 2 diabetes along with its complication have a 49% higher risk of Parkinson’s disease, while those having only type 2 diabetes without complications have a 30% risk of parkinson’s disease.
In particular, younger patients with diabetes (25 to 44 years of age) have an approximately fourfold increased risk of developing Parkinson's compared with adults of similar age without diabetes.
Researchers has estimated the high risk of developing PD based on longitudinal data methodology for people with type 2 diabetes.
Initial studies have reported more than 400 genes linked in both conditions.
The potential link between type 2 diabetes and Parkinson's disease has been the topic of medical dialogue and scientific research for years.
Recently, animal and in vitro studies have shown that the pathophysiology and clinical symptoms of Parkinson's disease are concerned more with insulin dysregulation and changes in insulin action.

Related Results

Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
In millennia, 40 million people were died with non-communicable diseases and diabetes is one of them. In diabetes, insulin secretions are not produced properly or resist to body an...
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
ABSTRAKDiabetes mellitus adalah suatu penyakit dengan peningkatan glukosa darah di atas normal. Indonesia merupakan negara menempati urutan ke 7 dengan penderita diabetes mellitus ...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE: To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
Insulin is one of the most important hormones that controls the glucose level in blood. Therefore, the investigation of insulin is very important for the diabetic research. There h...
Analysis of coping type II diabetes mellitus
Analysis of coping type II diabetes mellitus
Diabetes mellitus is a chronic disease that is a major health and social problem worldwide. This study aims to assess the coping process of patients with type II Diabetes Mellitus ...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...

Back to Top